Board okays Q1 results, re-appoints directors, AGM on 29 Sept

Related-party transactionsResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-8.6%Reaction day

₹142.50

prior close

₹138.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-8.7% vs market

Medical Equipment & Supplies peers, median of 11sector-0.1%-8.5% vs sector

On the reaction day the stock moved 8.7 pts less than Nifty Microcap 250 and 8.5 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

-1.4

15m

-1.4

30m

-1.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-8.6+0.1-8.7-0.1-8.5

Next day

-8.4+0.2-8.6-1.7-6.7

-7.4+0.6-7.9-1.2-6.2

-6.0-0.0-6.0+0.0-6.0

-5.3+0.5-5.8-1.3-4.0

-4.9+0.8-5.7-2.5-2.4

-4.7+0.6-5.3+1.4-6.1

15d

-2.5+1.3-3.7-0.1-2.4

+3.2-1.4+4.6-2.6+5.8

+12.4-0.6+13.0-6.2+18.6

—————

UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 11Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Shree Pacetronix board approved Q1 FY26-27 unaudited financial results (standalone and consolidated) with an unmodified auditor opinion. Also approved Board's report for FY25-26. 38th AGM set for 29 Sept 2026. Re-appointed Joint MD Akash Sethi for 3 more years and two independent directors (Ms. Manali Tongia and Ms. Somya Chhabra) for second 5-year terms. Approved increase in MD remuneration, subject to shareholder nod.

Likely market impact

Routine board business with director re-appointments and AGM scheduling. Remuneration hike for MD's son needs shareholder approval at AGM.